What is EPA’s Subpart P for Pharmaceutical Waste?
EPA passed regulations (40 CFR 266 Subpart P) that will affect everywhere pharmaceuticals are sold or administered. These sector specific regulations pertain to the handling, storage and transportation of hazardous waste pharmaceuticals (HWP) generated at healthcare facilities (HCF). Here’s an overview of what to expect.
- Healthcare facilities generate HWP
- Nationwide sewer ban on HWP info
- Each state must adopt – timeline info
- Nicotine (gum, patches, lozenges) non-hazardous info
- Pertain to pharmaceuticals that are hazardous (5-7% of formulary)
- Pharmaceuticals include prescription and OTC
- Facilities need to identify which drugs in their inventory are hazardous
- Required for SQG and LQG’s
- Optional for VSQG’s info
- most facilities qualify
- advantages of not participating
- Potentially creditable HWP’s info
- reasonable expectation to receive credit
- undispensed, < 1 year expired, original packaging
- send back to the RD via common carrier
- DOT regulations apply – shipping manifest optional
- Non-Creditable HWP’s info
- cannot be sent back to the RD
- RD required to notify EPA and HCF if received
- extensive requirements
- disposal by TSDF
- DOT regulations apply – shipping manifest required
- Relief – DEA controls that are HW info
- Relief – RCRA empty containers info
- Free webinar registration info
- PTI Porthole for EPA Subpart P compliance info
- PAC-RX™ – DEA medicine disposal device info
Register for a free webinar on EPA’s Subpart P which is given monthly and subscribe to our email list to receive industry email alerts and blogs as they become available.